ライブセルイメージング市場：製品（装置、消耗品、ソフトウェア、サービス）、用途（細胞生物学、幹細胞、創薬）、技術（タイムラプス顕微鏡、FRET、FRAP、HCS）、エンドユーザー（製薬、バイオテクノロジー、CROs） - 2028年までの世界予測

Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2028

ライブセルイメージングの世界市場は、2023年の27億米ドルから2028年には43億米ドルに達すると予測され、2023年から2028年の予測期間中に10.2%のCAGRで推移すると予測されています。この市場の成長は、創薬におけ... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年5月30日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	293	343	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

ライブセルイメージングの世界市場は、2023年の27億米ドルから2028年には43億米ドルに達すると予測され、2023年から2028年の予測期間中に10.2%のCAGRで推移すると予測されています。この市場の成長は、創薬におけるハイコンテントスクリーニング技術の採用が高い／伸びていることに起因していると考えられます。創薬においてハイスループット・スクリーニングやHCS技術への依存度が高まるにつれ、ライブセルイメージング技術への需要が高まることが予想されます。この傾向は、特に個別化医療の分野で顕著になると予想され、ライブセルイメージングは個々の患者に合わせた治療法を特定するために使用することができます。

"予測期間中の製品・サービス別シェアは、消耗品分野が2位"
2022年、ライブセルイメージングの世界市場において、消耗品セグメントは製品＆サービス別に2番目に大きなシェアを占めています。消耗品には、生細胞のイメージングと分析に使用されるさまざまな製品が含まれます。これらの消耗品は、サンプルの前処理、メンテナンス、分析に不可欠であるため、ライブセルイメージングのワークフローにおいて重要な役割を担っています。ライブセルイメージングに使用される消耗品には、試薬、培地、アッセイキット、その他マイクロプレート、スライド、ペトリ皿、カバースリップ、培養チャンバーなどの消耗品があります。消耗品は通常使い捨てで、定期的に補充する必要があるため、メーカーにとっては重要な経常収益の柱となっています。消耗品はライブセルイメージングに不可欠な要素であり、この分野の成長は主に、高度なイメージング技術への需要の高まりと、さまざまな研究用途におけるライブセル解析の採用拡大によってもたらされます。

"欧州 "です：ライブセルイメージング市場において2番目に大きな地域"
ヨーロッパは、ライブセルイメージングの市場において、北米に次ぐ2番目の規模を占めています。欧州のライブセルイメージング市場は、その拡大を後押しする様々な要因によって、近年著しい成長を遂げています。欧州は、ライブセルイメージング分野における新技術の開発・導入の最前線にある。これには、超解像顕微鏡、ハイスループットイメージング、シングルセルイメージング、マルチモーダルイメージングアプローチの進歩が含まれます。これらの革新的な技術の採用は、ライブセルイメージング研究の進展を加速させ、その応用を拡大させます。さらに、欧州ではライブセルイメージング技術に関する包括的なトレーニングや教育プログラムが提供されています。大学や研究機関、団体が、科学者や研究者の知識や技術を向上させるための専門コースやワークショップ、会議を開催しています。トレーニングプログラムの充実は、欧州におけるライブセルイメージング技術の導入と活用を促進します。

本レポートのために実施した一次インタビューは、以下のように分類される：

- 回答者別回答者別：供給側80％、需要側20
- 役職別Cレベル-45％、Dレベル-30％、その他-25
- 地域別北米：20％、欧州：10％、アジア太平洋：55％、中南米：10％、中近東・アフリカ：5
レポート掲載企業一覧
- Danaher社（米国）
- ZEISSグループ（ドイツ）
- 株式会社ニコン (日本)
- オリンパス株式会社 (日本)
- パーキンエルマー社 (米国)
- ザルトリウス社 (ドイツ)
- アジレント・テクノロジー株式会社（米国）
- サーモフィッシャーサイエンティフィック社（米国）
- Etaluma, Inc.（米国）
- CytoSMART Technologies（オランダ）
- NanoEnTek Inc.(韓国)
- GEヘルスケア（米国）
- ブルカーコーポレーション（米国）
- ベクトン・ディッキンソン・アンド・カンパニー（BD）（米国）
- メルクKGaA（ドイツ）
- バイオ・ラッド・ラボラトリーズ・インク（米国）
- ブルーレイバイオテック社（台湾）
- CYTENA GmbH (ドイツ)
- Nanolive SA（スイス）
- Abberior (ドイツ)
- Phase Holographic Imaging (PHI) AB（スウェーデン）
- サイトスケルトン・インク（米国）Cytoskeleton, Inc.
- コーニング・インコーポレイテッド (米国)
- 株式会社キーエンス (日本)
- アラインドジェネティクス社（韓国）

調査範囲です：
本レポートは、ライブセルイメージング市場の詳細な情報を提供します。製品＆サービス、アプリケーション、テクノロジー、エンドユーザー、地域などの異なるセグメントにおける市場規模と今後の成長可能性を推定することを目的としています。また、主要な市場プレイヤーの会社概要や最近の開発状況、主要な市場戦略とともに、詳細な競合分析も行っています。
レポートを購入する主な利点
本レポートは、市場全体とそのサブセグメントにおける収益数の最も近い近似値を提供することで、市場リーダーや新規参入者の助けとなります。また、利害関係者が競争環境をよりよく理解し、より多くの洞察を得ることで、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てることができるようになるでしょう。本レポートは、関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、機会、および課題に関する情報を提供することを可能にします。
以下のポイントに関する洞察を提供します：
- 市場成長に影響を与える主要な推進要因（創薬におけるハイコンテンツスクリーニング技術の採用拡大、癌の発生率上昇、研究資金の増加）、阻害要因（ハイコンテンツスクリーニングシステムの高コスト）、機会（新興市場におけるライブセルイメージング技術の採用拡大、個別化医療におけるHCSの応用）、課題（細胞培養における細胞生存率と細胞環境の維持、画像解析とデータ管理）についての分析。
- 製品およびサービスの開発/革新：新たに発売された製品・サービスに関する詳細な洞察と、ライブセルイメージング市場の技術的評価
- 市場開発：有利な市場に関する包括的な情報 - 本レポートでは、さまざまな地域の市場を分析しています。
- 市場の多様化：ライブセルイメージング市場における新製品・サービス、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。
- 競争力のある評価：Danaher社（米国）、ZEISS Group社（ドイツ）、株式会社ニコン（日本）、オリンパス株式会社（日本）、PerkinElmer社（米国）、Sartorius AG（ドイツ）、Agilent Technologies社（米国）、Thermo Fisher Scientific社（米国）、Etaruma社（米国）、Cytoothmart Technologies社（オランダ）、NanoEnTek Inc.など大手企業の市場シェア、成長戦略、製品やサービスの提供について詳細に評価する。(韓国）、GEヘルスケア（米国）、ブルカーコーポレーション（米国）、ベクトン・ディッキンソン＆カンパニー（BD）（米国）、メルクKGaA（ドイツ）、バイオ・ラッド・ラボラトリーズ（米国）、ブルーレイバイオテック（米国）、NanoEnTek Inc.(台湾)、CYTENA GmbH (ドイツ)、Nanolive SA (スイス)、Abberior (ドイツ)、Phase Holographic Imaging (PHI) AB (スウェーデン)、Cytoskeleton, Inc. (US), Corning Incorporated (US), KEYENCE Corporation (Japan), Aligned Genetics, Inc. (Korea) など、多くの企業が市場に参加しています。

ページTOPに戻る

1 INTRODUCTION 41
1.1 STUDY OBJECTIVES 41
1.2 MARKET DEFINITION 41
1.2.1 INCLUSIONS & EXCLUSIONS 42
1.3 MARKET SCOPE 42
FIGURE 1 LIVE CELL IMAGING MARKET SEGMENTATION 42
1.3.1 YEARS CONSIDERED 43
1.4 CURRENCY 43
1.5 LIMITATIONS 43
1.6 STAKEHOLDERS 44
1.7 SUMMARY OF CHANGES 44
1.7.1 RECESSION IMPACT 45
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH DATA 46
FIGURE 2 RESEARCH DESIGN 46
2.1.1 SECONDARY DATA 47
2.1.2 PRIMARY DATA 47
FIGURE 3 LIVE CELL IMAGING MARKET: BREAKDOWN OF PRIMARIES 48
2.2 MARKET SIZE ESTIMATION 49
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022 49
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022 50
FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS, 2022 51
2.2.1 INSIGHTS FROM PRIMARIES 52
FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS 52
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 52
2.3 GROWTH FORECAST 53
FIGURE 9 LIVE CELL IMAGING MARKET: CAGR PROJECTIONS, 2022–2028 54
FIGURE 10 LIVE CELL IMAGING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 55
FIGURE 11 DATA TRIANGULATION METHODOLOGY 55
2.5 RESEARCH ASSUMPTIONS 56
2.6 RISK ANALYSIS 56
2.7 RECESSION IMPACT ON LIVE CELL IMAGING MARKET 56
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 57
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 57
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 57
3 EXECUTIVE SUMMARY 59
FIGURE 12 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 59
FIGURE 13 LIVE CELL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 60
FIGURE 14 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 60
FIGURE 15 LIVE CELL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 61
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF LIVE CELL IMAGING MARKET 62
4 PREMIUM INSIGHTS 63
4.1 LIVE CELL IMAGING MARKET OVERVIEW 63
FIGURE 17 GROWING ADOPTION OF HIGH-CONTENT SCREENING TECHNIQUES IN DRUG DISCOVERY TO DRIVE MARKET GROWTH 63
4.2 NORTH AMERICA: LIVE CELL IMAGING MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2022) 64
FIGURE 18 INSTRUMENTS DOMINATED NORTH AMERICAN LIVE CELL IMAGING MARKET IN 2022 64
4.3 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 65
FIGURE 19 INSTRUMENTS TO CONTINUE TO DOMINATE MARKET BY 2028 65
4.4 LIVE CELL IMAGING MARKET SHARE, BY END USER, 2022 65
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 65
4.5 LIVE CELL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 66
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN LIVE CELL IMAGING MARKET FROM 2023 TO 2028 66
5 MARKET OVERVIEW 67
5.1 INTRODUCTION 67
5.2 MARKET DYNAMICS 67
FIGURE 22 LIVE CELL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 67
TABLE 4 LIVE CELL IMAGING MARKET: IMPACT ANALYSIS 68
5.2.1 DRIVERS 68
5.2.1.1 Growing adoption of high-content screening techniques in drug discovery 68
5.2.1.2 Rising incidence of cancer 69
TABLE 5 ESTIMATED NEW CANCER CASES IN US, 2023 69
FIGURE 23 GLOBAL CANCER INCIDENCE & MORTALITY, 2020 70
5.2.1.3 Growing availability of research funds 70
TABLE 6 INVESTMENT BREAKDOWN, 2021 (USD MILLION) 72
5.2.2 RESTRAINTS 72
5.2.2.1 High cost of high-content screening systems 72
5.2.3 OPPORTUNITIES 73
5.2.3.1 Increasing adoption of live cell imaging technologies in emerging economies 73
5.2.3.2 Applications of HCS in personalized medicine 73
5.2.4 CHALLENGES 74
5.2.4.1 Maintaining cell viability and cellular environment in cell cultures 74
5.2.4.2 Image analysis and data management 74
5.3 TECHNOLOGY ANALYSIS 75
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 76
FIGURE 24 REVENUE SHIFT & NEW POCKETS FOR LIVE CELL IMAGING PRODUCT & SERVICE PROVIDERS 77
5.5 VALUE/SUPPLY CHAIN ANALYSIS 77
5.5.1 VALUE CHAIN ANALYSIS 77
FIGURE 25 LIVE CELL IMAGING MARKET: VALUE CHAIN ANALYSIS 78
5.5.2 SUPPLY CHAIN ANALYSIS 79
FIGURE 26 LIVE CELL IMAGING MARKET: SUPPLY CHAIN ANALYSIS 79
5.6 REGULATORY ANALYSIS 80
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
5.6.1.1 North America 80
5.6.1.1.1 US 80
5.6.1.1.2 Canada 80
5.6.1.2 Europe 80
5.6.1.3 Asia Pacific 81
5.6.1.4 Rest of the World 81
5.7 PORTER’S FIVE FORCES ANALYSIS 82
TABLE 7 LIVE CELL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 82
5.7.1 THREAT OF NEW ENTRANTS 82
5.7.2 THREAT OF SUBSTITUTES 82
5.7.3 BARGAINING POWER OF SUPPLIERS 82
5.7.4 BARGAINING POWER OF BUYERS 82
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 83
5.8 ECOSYSTEM ANALYSIS 83
TABLE 8 SUPPLY CHAIN ECOSYSTEM 83
5.9 PRICING ANALYSIS 85
5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER 85
TABLE 9 AVERAGE SELLING PRICES 85
5.9.2 AVERAGE SELLING PRICE TREND 86
5.10 KEY CONFERENCES & EVENTS IN 2022–2023 86
TABLE 10 LIVE CELL IMAGING: DETAILED LIST OF CONFERENCES & EVENTS 86
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 88
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 88
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF LIVE CELL IMAGING PRODUCTS 88
5.11.2 BUYING CRITERIA FOR LIVE CELL IMAGING 88
FIGURE 28 KEY BUYING CRITERIA FOR END USERS 88
5.12 PATENT ANALYSIS 89
FIGURE 29 LIVE CELL IMAGING MARKET: PATENT APPLICATIONS (JANUARY 2020–APRIL 2023) 89
6 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE 90
6.1 INTRODUCTION 91
TABLE 11 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 91
6.2 INSTRUMENTS 92
TABLE 12 EXAMPLES OF INSTRUMENTS OFFERED BY MARKET PLAYERS 92
TABLE 13 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 14 LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 93
TABLE 15 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 16 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 17 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 18 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
6.2.1 MICROSCOPES 95
6.2.1.1 Continuous technological advancements in microscopes to support market 95
TABLE 19 CONVENTIONAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS 96
TABLE 20 CONFOCAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS 97
TABLE 21 FLUORESCENCE MICROSCOPES OFFERED BY KEY MARKET PLAYERS 98
TABLE 22 LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2021–2028 (USD MILLION) 98
TABLE 23 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 24 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 25 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 26 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION) 100
6.2.2 STANDALONE SYSTEMS 100
6.2.2.1 Seamless integration and workflow efficiency of standalone systems to boost demand 100
TABLE 27 STANDALONE SYSTEMS OFFERED BY KEY MARKET PLAYERS 100
TABLE 28 LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 29 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 30 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 31 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 32 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 102
6.2.3 CELL ANALYZERS 102
6.2.3.1 Accuracy and reproducibility of cell analyzers to support growth 102
TABLE 33 CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS 103
TABLE 34 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION) 103
TABLE 35 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 36 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 37 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 38 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 104
6.2.4 ACCESSORIES 105
6.2.4.1 Ability of accessories to optimize and enhance imaging conditions to boost demand 105
TABLE 39 ACCESSORIES OFFERED BY KEY MARKET PLAYERS 105
TABLE 40 LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 41 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 42 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 43 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 44 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 107
6.3 CONSUMABLES 108
TABLE 45 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 46 LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 47 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 48 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 49 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 50 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
6.3.1 REAGENTS 110
6.3.1.1 Widespread usage in life science research to fuel market growth 110
TABLE 51 REAGENTS OFFERED BY KEY MARKET PLAYERS 111
TABLE 52 LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 53 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 54 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 55 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 56 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 113
6.3.2 ASSAY KITS 113
6.3.2.1 Repeat purchase of assay kits to drive market 113
TABLE 57 ASSAY KITS OFFERED BY KEY MARKET PLAYERS 113
TABLE 58 LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 59 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 60 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 61 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 62 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 115
6.3.3 MEDIA 116
6.3.3.1 Increasing demand for optimized cell culture conditions to drive demand for media 116
TABLE 63 MEDIA OFFERED BY KEY MARKET PLAYERS 116
TABLE 64 LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY REGION, 2021–2028 (USD MILLION) 116
TABLE 65 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 66 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 67 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 68 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION) 118
6.3.4 OTHER CONSUMABLES 118
TABLE 69 OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS 119
TABLE 70 OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 71 NORTH AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 72 EUROPE: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 73 ASIA PACIFIC: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 74 LATIN AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
6.4 SOFTWARE 121
6.4.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGE ACQUISITION TO BOOST MARKET GROWTH 121
TABLE 75 SOFTWARE OFFERED BY KEY MARKET PLAYERS 121
TABLE 76 LIVE CELL IMAGING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION) 122
TABLE 77 NORTH AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 78 EUROPE: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 79 ASIA PACIFIC: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 80 LATIN AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
6.5 SERVICES 124
6.5.1 GROWING DEMAND FOR OUTSOURCED EXPERTISE AND SPECIALIZED SERVICES TO SUPPORT MARKET 124
TABLE 81 LIVE CELL IMAGING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 82 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 83 EUROPE: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 84 ASIA PACIFIC: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 85 LATIN AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
7 LIVE CELL IMAGING MARKET, BY APPLICATION 127
7.1 INTRODUCTION 128
TABLE 86 LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128
7.2 CELL BIOLOGY 128
TABLE 87 NUMBER OF NEW CANCER CASES, BY TYPE, 2020 VS. 2040 129
TABLE 88 LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 130
TABLE 89 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 90 EUROPE: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 91 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 92 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 131
7.3 STEM CELLS 131
7.3.1 GROWING FOCUS ON REGENERATIVE MEDICINE & ADVANCEMENTS IN STEM CELL RESEARCH TO BOOST MARKET 131
TABLE 93 LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 132
TABLE 94 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 95 EUROPE: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 96 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 97 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 133
7.4 DEVELOPMENTAL BIOLOGY 134
7.4.1 GROWING INTEREST IN UNDERSTANDING ORGANOGENESIS AND TISSUE MORPHOGENESIS TO DRIVE DEMAND 134
TABLE 98 LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 99 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 100 EUROPE: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 101 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 102 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 136
7.5 DRUG DISCOVERY 136
7.5.1 GROWING USE OF HCS CELL-BASED ASSAYS IN DRUG DISCOVERY STUDIES TO DRIVE DEMAND 136
TABLE 103 LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 137
TABLE 104 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 105 EUROPE: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 106 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 107 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 138
8 LIVE CELL IMAGING MARKET, BY TECHNOLOGY 139
8.1 INTRODUCTION 140
TABLE 108 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 140
8.2 TIME-LAPSE MICROSCOPY 140
TABLE 109 LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION, 2021–2028 (USD MILLION) 141
TABLE 110 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 111 EUROPE: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 112 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 113 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 142
8.3 FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) 143
8.3.1 ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES TO BOOST ADOPTION OF FRET TECHNOLOGY 143
TABLE 114 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY REGION, 2021–2028 (USD MILLION) 143
TABLE 115 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 116 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 117 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 118 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION) 144
8.4 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP) 145
8.4.1 INTEGRATION OF FRAP WITH LIVE CELL IMAGING MICROSCOPY TO CONTRIBUTE TO MARKET GROWTH 145
TABLE 119 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY REGION, 2021–2028 (USD MILLION) 145
TABLE 120 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 121 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 122 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 123 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION) 147
8.5 HIGH-CONTENT SCREENING (HCS) 147
8.5.1 GROWING ADOPTION OF HCS IN DRUG DISCOVERY AND TOXICITY SCREENING TO DRIVE GROWTH 147
TABLE 124 LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2021–2028 (USD MILLION) 148
TABLE 125 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 126 EUROPE: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 127 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 128 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 149

8.6 OTHER TECHNOLOGIES 149
TABLE 129 LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION) 150
TABLE 130 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 131 EUROPE: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 132 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 133 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 151
9 LIVE CELL IMAGING MARKET, BY END USER 152
9.1 INTRODUCTION 153
TABLE 134 LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 153
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 153
9.2.1 NEED TO ADHERE TO STRICT REGULATIONS TO DRIVE USE OF LIVE CELL IMAGING PRODUCTS AMONG PHARMA COMPANIES 153
TABLE 135 LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 154
TABLE 136 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 137 EUROPE: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 138 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 139 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
9.3 ACADEMIC & RESEARCH INSTITUTES 156
9.3.1 INCREASING NUMBER OF DRUG DISCOVERY RESEARCH PROGRAMS TO DRIVE MARKET GROWTH 156
TABLE 140 LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 156
TABLE 141 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 142 EUROPE: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 143 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 144 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 158
9.4 CONTRACT RESEARCH ORGANIZATIONS 158
9.4.1 GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE DEMAND 158
TABLE 145 LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION) 159
TABLE 146 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 147 EUROPE: LIVE CELL IMAGING MARKET FOR F CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 148 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 149 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 160
10 LIVE CELL IMAGING MARKET, BY REGION 161
10.1 INTRODUCTION 162
TABLE 150 LIVE CELL IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION) 162
10.2 NORTH AMERICA 162
FIGURE 30 NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT 163
TABLE 151 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 152 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 164
TABLE 153 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 154 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 155 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165
TABLE 156 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 166
TABLE 157 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 166
10.2.1 US 167
10.2.1.1 US to dominate live cell imaging market in North America 167
TABLE 158 US: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 167
TABLE 159 US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 160 US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 161 US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 168
TABLE 162 US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 169
TABLE 163 US: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 169
10.2.2 CANADA 169
10.2.2.1 Government initiatives to promote research to support market growth 169
TABLE 164 CANADA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 170
TABLE 165 CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 166 CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 167 CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171
TABLE 168 CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 171
TABLE 169 CANADA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 172
10.2.3 NORTH AMERICA: RECESSION IMPACT 172
10.3 EUROPE 173
TABLE 170 EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 171 EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 174
TABLE 172 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 173 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 174 EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 175
TABLE 175 EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 175
TABLE 176 EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 176
10.3.1 GERMANY 176
10.3.1.1 Presence of large number of academic research institutes to boost market 176
TABLE 177 GERMANY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 177
TABLE 178 GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 179 GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 180 GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 178
TABLE 181 GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 179
TABLE 182 GERMANY: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 179
10.3.2 UK 180
10.3.2.1 Investments by pharmaceutical sponsors for drug discovery services to support market 180
FIGURE 31 UK: PHARMACEUTICAL R&D EXPENDITURE, 2011–2020 (USD MILLION) 180
TABLE 183 UK: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 181
TABLE 184 UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 185 UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 186 UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 182
TABLE 187 UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 182
TABLE 188 UK: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 183
10.3.3 FRANCE 183
10.3.3.1 Large pharmaceutical manufacturing industry to drive market growth 183
TABLE 189 FRANCE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 184
TABLE 190 FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 191 FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 192 FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 185
TABLE 193 FRANCE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 186
TABLE 194 FRANCE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 186
10.3.4 ITALY 186
10.3.4.1 Strong research tradition, government funding, and collaborative research networks to fuel growth 186
TABLE 195 ITALY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 187
TABLE 196 ITALY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 197 ITALY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 198 ITALY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 188
TABLE 199 ITALY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 189
TABLE 200 ITALY: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 189
10.3.5 SPAIN 190
10.3.5.1 Rising R&D expenditure to boost market 190
TABLE 201 SPAIN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 190
TABLE 202 SPAIN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 203 SPAIN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 204 SPAIN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 191
TABLE 205 SPAIN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 192
TABLE 206 SPAIN: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 192
10.3.6 REST OF EUROPE 192
TABLE 207 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 193
TABLE 208 REST OF EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 209 REST OF EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 210 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 194
TABLE 211 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 195
TABLE 212 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 195
10.3.7 EUROPE: RECESSION IMPACT 196

ページTOPに戻る

Table of Contents

Summary

The global live cell imaging market is projected to reach USD 4.3 billion by 2028 from USD 2.7 billion in 2023, at a CAGR of 10.2% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the high/growing adoption of high-content screening techniques in drug discovery. As drug discovery becomes increasingly reliant on high-throughput screening and HCS techniques, the demand for live cell imaging technology is likely to grow. This trend is expected to be particularly pronounced in the field of personalized medicine, where live cell imaging can be used to identify treatments tailored to individual patients.

“The consumables segment accounted for the second-largest share by product & service during the forecast period”
In 2022, consumables segment accounted for the second-largest share by product & service in the global live cell imaging market. Consumables include a range of products that are used in the imaging and analysis of live cells. These consumables play an important role in the live cell imaging workflow, as they are essential for sample preparation, maintenance, and analysis. Consumables used in live cell imaging include reagents, media, assay kits, and other consumables such as microplates, slides, Petri dishes, coverslips, and culture chambers. Consumables are typically disposable and need to be replenished regularly, making them an important recurring revenue stream for manufacturers. Consumables are an integral part of live cell imaging, and growth in this segment is mainly driven by the increasing demand for advanced imaging technologies and the growing adoption of live cell analysis in various research applications.

“Europe: The second largest region in the live cell imaging market”
Europe accounted for the second-largest market for live cell imaging after North America. The European live cell imaging market has witnessed significant growth in recent years, driven by various factors that have propelled its expansion. Europe is at the forefront of developing and adopting emerging technologies in the field of live cell imaging. This includes advancements in super-resolution microscopy, high-throughput imaging, single-cell imaging, and multi-modal imaging approaches. The adoption of these innovative technologies accelerates the progress of live cell imaging research and expands its applications. Additionally, Europe offers comprehensive training and education programs in live cell imaging techniques. Universities, research institutes, and organizations provide specialized courses, workshops, and conferences to enhance the knowledge and skills of scientists and researchers. The availability of training programs promotes the adoption and utilization of live cell imaging technologies in Europe.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80% and Demand Side 20%
• By Designation: C-level - 45%, D-level - 30%, and Others - 25%
• By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%
List of Companies Profiled in the Report:
• Danaher (US)
• ZEISS Group (Germany)
• Nikon Corporation (Japan)
• Olympus Corporation (Japan)
• PerkinElmer Inc. (US)
• Sartorius AG (Germany)
• Agilent Technologies, Inc. (US)
• Thermo Fisher Scientific, Inc. (US)
• Etaluma, Inc. (US)
• CytoSMART Technologies (Netherlands)
• NanoEnTek Inc. (South Korea)
• GE Healthcare (US)
• Bruker Corporation (US)
• Becton, Dickinson and Company (BD) (US)
• Merck KGaA (Germany)
• Bio-Rad Laboratories, Inc. (US)
• Blue-Ray Biotech Corp. (Taiwan)
• CYTENA GmbH (Germany)
• Nanolive SA (Switzerland)
• Abberior (Germany)
• Phase Holographic Imaging (PHI) AB (Sweden)
• Cytoskeleton, Inc. (US)
• Corning Incorporated (US)
• KEYENCE Corporation (Japan)
• Aligned Genetics, Inc. (South Korea)

Research Coverage:
This report provides a detailed picture of the live cell imaging market. It aims at estimating the size and future growth potential of the market across different segments such as the product & service, application, technology, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
The report provides insights on the following pointers:
• Analysis of key drivers (growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and growing availability of funds for research), restraints (High cost of high-content screening systems), opportunities (increasing adoption of live cell imaging technologies in emerging markets, and application of HCS in personalized medicine), and challenges (maintaining cell viability and cellular environment in cell cultures, and image analysis and data management) influencing the growth of the market.
• Product and Service Development/Innovation: Detailed insights on newly launched products & services, and technological assessment of the live cell imaging market
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the live cell imaging market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and products and service offerings of leading players like Danaher (US), ZEISS Group (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer Inc. (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Thermo Fisher Scientific, Inc. (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), NanoEnTek Inc. (South Korea), GE Healthcare (US), Bruker Corporation (US), Becton, Dickinson and Company (BD) (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Blue-Ray Biotech Corp. (Taiwan), CYTENA GmbH (Germany), Nanolive SA (Switzerland), Abberior (Germany), Phase Holographic Imaging (PHI) AB (Sweden), Cytoskeleton, Inc. (US), Corning Incorporated (US), KEYENCE Corporation (Japan), Aligned Genetics, Inc. (South Korea), and among others in the market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（consumables）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（consumables）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?